Valuation: AstraZeneca PLC

Market Cap 29TCr 26TCr 24TCr 22TCr 41TCr 27,14300Cr 42TCr 2,85300Cr 1,13800Cr 14,48300Cr 1,08400Cr 1,06100Cr 45,72200Cr P/E 2026 *
24.5x
P/E 2027 * 20.9x
Enterprise Value 31TCr 28TCr 25TCr 23TCr 44TCr 29,10100Cr 45TCr 3,05900Cr 1,22000Cr 15,52800Cr 1,16200Cr 1,13700Cr 49,02000Cr EV / Sales 2026 *
4.89x
EV / Sales 2027 * 4.49x
Free-Float
96.62%
Yield 2026 *
1.79%
Yield 2027 * 1.9%
1 day-0.22%
Current month+100.96%
Current year+102.80%
Current year 89.04
Extreme 89.04
187.33
1 year 85.84
Extreme 85.845
187.33
3 years 60.47
Extreme 60.47
187.33
5 years 52.65
Extreme 52.65
187.33
10 years 25.55
Extreme 25.55
187.33
Manager TitleAgeSince
Chief Executive Officer 66 01/10/2012
Director of Finance/CFO 52 01/08/2021
Chief Operating Officer 55 01/06/2015
Director TitleAgeSince
Director/Board Member 70 06/04/1999
Director/Board Member 66 01/10/2012
Director/Board Member 65 27/04/2017
Change 5-day change 1-year change 3-year change Capi.($)
-0.22%-0.12% - - 29TCr
-0.79%-4.48%+46.48%+118.69% 1,20600Cr
+1.43%+1.11%+48.05%+83.72% 66TCr
+1.07%-1.21%+32.92%+105.10% 51TCr
-0.36%-3.25%+45.42%+63.89% 38TCr
-0.14%-1.87%+70.06%+40.55% 36TCr
-0.78%-0.52%+30.47%+56.79% 31TCr
-0.80%-0.21%+7.98%+36.97% 29TCr
+0.03%-1.20%+43.79%+68.49% 25TCr
-0.41%-2.22%+40.43%+114.24% 21TCr
Average -0.10%-1.54%+40.62%+76.49% 46.44TCr
Weighted average by Cap. -0.06%-1.96%+42.71%+86.30%

Financials

2026 *2027 *
Net sales 6.34TCr 5.68TCr 5.19TCr 4.74TCr 8.93TCr 5,95600Cr 9.21TCr 63TCr 25TCr 3,17800Cr 24TCr 23TCr 10,03200Cr 6.74TCr 6.04TCr 5.52TCr 5.04TCr 9.5TCr 6,33500Cr 9.8TCr 67TCr 27TCr 3,38000Cr 25TCr 25TCr 10,67100Cr
Net income 1.17TCr 1.05TCr 960.83Cr 877.09Cr 1.65TCr 1,10200Cr 1.7TCr 12TCr 4.62TCr 59TCr 4.4TCr 4.31TCr 1,85600Cr 1.36TCr 1.22TCr 1.11TCr 1.02TCr 1.92TCr 1,27800Cr 1.98TCr 13TCr 5.36TCr 68TCr 5.1TCr 4.99TCr 2,15200Cr
Net Debt 2.08TCr 1.87TCr 1.71TCr 1.56TCr 2.94TCr 1,95800Cr 3.03TCr 21TCr 8.21TCr 1,04500Cr 7.82TCr 7.65TCr 3,29900Cr 1.36TCr 1.22TCr 1.12TCr 1.02TCr 1.92TCr 1,28300Cr 1.98TCr 13TCr 5.38TCr 68TCr 5.12TCr 5.01TCr 2,16100Cr
Projected Income Statement - Annual - AstraZeneca PLC
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
06/26/06 $186.43 -0.22% 28,47,144
05/26/05 $186.85 -1.14% 48,42,575
04/26/04 $189.01 +2.79% 45,56,299
03/26/03 $183.88 -1.45% 38,85,246
02/26/02 $186.58 -0.04% 26,99,445
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - AstraZeneca PLC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
186.17USD
Average target price
215.04USD
Spread / Average Target
+15.51%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - AstraZeneca PLC